Chloroquine and cardiac arrhythmia: Case report

East African Medical Journal

Volumn 75, Issue 2, 1998, Pages 117-119

  Siqueira Batista, R ^a   Ramos Jr , A N ^b   Pessanha, B S ^b   Sforza De Almeida, M P ^b   Vigo Potsch, D F ^b  

^a Serv de Doencas Infecc/Parasit   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; CHLOROQUINE; PRIMAQUINE;

ADULT; ARTICLE; AUSCULTATION; BLOOD SMEAR; CASE REPORT; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HUMAN; MALARIA; MALE; PLASMODIUM VIVAX; SUPRAVENTRICULAR PREMATURE BEAT;

ANTIMALARIALS; ATRIAL PREMATURE COMPLEXES; BRAZIL; CHLOROQUINE; ELECTROCARDIOGRAPHY; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED;

PLASMODIUM VIVAX;

EID: 0031819595     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cot M., Hersran L.E., Miailhes P., Esveld M., Etya'ale D. and Breart G. Increase of birth weight following chloroquine chemoprofilaxis during the first pregnancy: results of a randomized trial in Cameroon. Amer. J. trop. Med. Hyg. 1995; 53: 581-585.
2. Martins F.S.V., Santos G.C.T and Ramos Filho C.F. Malaria. In: Schechter M and Marangoni D.V. Doencas Infecciosas: Conduta Diagnostica e Terapeutica. Rio de Janeiro, Guanabara Koogan, 1994.
3. Warrell, D.A., Molyneux, M.E. and Beales, P.F. Severe and Complicated malaria. Trans. roy. Soc. trop. Med. Hyg. Second edition. 1990; 84:S2.
4. Wyler D.J. Malaria chemoprofilaxis for the traveler N. Engl. J. Med. 1993; 1: 31-37.
5. Iglesias-Cubero G., Rodriguez-Reguero J.J. and Rojo-Ortega J.M. Restrictive cardiomyopathy caused by chloroquine. Brit. Heart. J., 1993; 69:451-452.
6. Ihenacho H.N. and Magulike E. Cloroquine abuse and heart block in Africans. Aust. N.Z.J. Med., 1989; 19:17-21.
7. Ogola E.S., Muita A.K. and Adala H. Chloroquine related complete heart block with blindness: case report. East Afr Med J, 1992; 69:50-52.
8. Verny C., De-Germes C., Sebastien P., Le-Thi H.D., Chapelon C., Piette J.C., Chomette G. and Godeau P. Heart conduction disorders in long-term treatment with chloroquine. Two new cases. Presse Med, 1992; 21:800-804.
9. Bustos M.D., Gay F., Diquel B., Thomare P. and Warot D. The pharmacokinetics and eletrocardiographic effects of chloroquine in healthy subjects. Trop. Med. Parasit. 1994; 45:83-86.
10. Suparanond W., Davis T.M., Pukrittayakamee S., Nagachinta B. and White N.J. Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs. Ear J Clin Pharmacol. 1993; 44:325-9.
11. Giudicelli C.P., Touze J.E. and Bernard J. Electrocardiographic changes due halofantrine in treatment of malaria: therapeutic implications. Bull. Acad. Natl. Med., 1996; 180: 1.
12. Matson P.A., Luby S.P., Redd S.C., Rolka H.R. and Meriwether R. A. Cardiac effects of standard-dose halofantrine therapy. Amer. J. trop. Med. Hyg., 1996; 54:229-31.
13. Nosten F., ter Kuile F.O., Luxemburger C., Woodrow C., Kyle D.E., Chongsuphajaisiddhi T. and White N.J. Cardiac effects of antimalarial treatment with halofantrine. Lancet, 1993; 341: 1054-6.
14. Touze J.E., Bernard J., Keundjian A., Impert P., Viguier A., Chaudet H. and Doury J.C. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Amer. J. trop. Hyg., 1996; 54:225-8.
15. Touze J.E., Peyron F., Mojon M. and Fourcade L. Halofantrine: for new rules of prescription. Presse. Med., 1995; 24:366-9.
16. Brewer T.G., Peggins J.O. and Grate S.J. et al. Neurotoxicity in animals due to arteether and artemether. Trans roy. Soc trop. Med. Hyg., 1994; 88 Supl 1: S33-6.
17. Laothavom P., Karbwang J., Bangchang Potassio, N.A., Bunnag D. and Harinasuta T. Effect of mefloquine on electrotardiographic changes in uncomplicated falciparum malaria patients. Southeast Asian J. trop. Med. Pub. Hlth.; 1992; 23:51-4.